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Dear Editor,  
Recently, Agapios Sachinidis and colleagues from the University of Cologne published a 
review about possibilities and limitations of stem cell-based test methods in pharmacology and 
toxicology (Sachinidis et al., 2019). In recent years, much progress has been achieved concern-
ing in vitro techniques of liver (Godoy et al., 2013; Grinberg et al., 2014; Leist et al., 2017; 
Ghallab et al., 2016), kidney (Sjögren et al., 2018; Jiang et al., 2018; Su et al., 2016; Valente et 
al., 2012; Lee et al., 2017), neuronal (Keil et al., 2018; Yang et al., 2018; Colaianna et al., 2017; 
Sisnaiske et al., 2014) and developmental toxicity (Adam et al., 2019; Bridges et al., 2019; 
Abbott, 2019). Particularly, in developmental and reproductive toxicity testing, large numbers 
of animals are needed for analysis of a single compound (Krug et al., 2013). Therefore, stem 
cell-based test systems are currently developed (Shinde et al., 2014, 2015, 2016; Krug et al., 
2013; Meganathan et al., 2012). They recapitulate differentiation into cells of the three germ 
layers (Meganathan et al., 2012; Shinde et al., 2016, 2017) or differentiation into neural ecto-
dermal progenitor cells (Rempel et al., 2015; Waldmann et al., 2014). Stem cells are exposed 
to test compounds during the differentiation process and compound associated gene expression 
changes are monitored.  
Indices have been developed to identify a possible hazard of developmental toxicity based 
on genome-wide expression data. A precondition is the definition of so-called developmental 
genes of a test system. Developmental genes are up- or down-regulated during the differentia-
tion process in the absence of test compounds. Developmental potency describes the fraction 
of all developmental genes, whose expression is altered by test compounds (Shinde et al., 2017). 
Although large validation studies are still required, several developmental toxicants, e.g. tha-
lidomide and valproic acid, have been successfully differentiated from negative control com-
pounds (Meganathan et al., 2012; Waldmann et al., 2014).  
Much progress has been achieved in analyzing disturbed developmental processes. How-
ever, it still remains challenging to differentiate stem cells to adult cell types that closely re-
semble the corresponding mature cell type in vivo (Godoy et al., 2015; Cameron et al., 2015). 
The authors of the present review describe why this is so difficult, using stem cell derived 
hepatocyte-like cells as an example (Sachinidis et al., 2019). Problems are due to incomplete 
endoderm patterning (Zorn, 2008; Gordillo et al., 2015) and to still suboptimal protocols to 
trigger the final differentiation of hepatoblasts to mature hepatocytes.  
Stem cell-based alternative test methods offer powerful tools to analyze developmental tox-
icity in vitro, but there is still a long way to go until the techniques are ready for routine use 
and to replace animal studies in pharmacology and toxicology.  
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